Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 144

1.

Giant Solitary Fibrous Tumor of Pleura Presenting Both Benign and Malignant Features.

Yagyu H, Hara Y, Murohashi K, Ishikawa Y, Isaka T, Woo T, Kaneko T.

Am J Case Rep. 2019 Nov 27;20:1755-1759. doi: 10.12659/AJCR.919639.

2.

"Return to the Soil" Nanopaper Sensor Device for Hyperdense Sensor Networks.

Kasuga T, Yagyu H, Uetani K, Koga H, Nogi M.

ACS Appl Mater Interfaces. 2019 Nov 20;11(46):43488-43493. doi: 10.1021/acsami.9b13886. Epub 2019 Nov 8.

PMID:
31659891
3.

Diagnosis of female 17α-hydroxylase deficiency after gonadectomy: a case report.

Mikami Y, Takai Y, Obata-Yasuoka M, Kumagai R, Yagyu H, Shigematsu K, Huang H, Uemura N, Shinsaka M, Saitoh M, Baba K, Seki H.

J Med Case Rep. 2019 Jul 30;13(1):235. doi: 10.1186/s13256-019-2166-9.

4.

Critical Role of SREBP-1c Large-VLDL Pathway in Environment-Induced Hypertriglyceridemia of Apo AV Deficiency.

Takanashi M, Kimura T, Li C, Tanaka M, Matsuhashi A, Yoshida H, Noda A, Xu P, Takase S, Okazaki S, Iizuka Y, Kumagai H, Ikeda Y, Gotoda T, Takahashi M, Yagyu H, Ishibashi S, Yamauchi T, Kadowaki T, Liang G, Okazaki H.

Arterioscler Thromb Vasc Biol. 2019 Mar;39(3):373-386. doi: 10.1161/ATVBAHA.118.311931.

PMID:
30700132
5.

Glucocorticoid receptor suppresses gene expression of Rev-erbα (Nr1d1) through interaction with the CLOCK complex.

Murayama Y, Yahagi N, Takeuchi Y, Aita Y, Mehrazad Saber Z, Wada N, Li E, Piao X, Sawada Y, Shikama A, Masuda Y, Nishi-Tatsumi M, Kubota M, Izumida Y, Miyamoto T, Sekiya M, Matsuzaka T, Nakagawa Y, Sugano Y, Iwasaki H, Kobayashi K, Yatoh S, Suzuki H, Yagyu H, Kawakami Y, Shimano H.

FEBS Lett. 2019 Feb;593(4):423-432. doi: 10.1002/1873-3468.13328. Epub 2019 Feb 1.

6.

Investigating the sequence-dependent mechanical properties of DNA nicks for applications in twisted DNA nanostructure design.

Lee JY, Kim YJ, Lee C, Lee JG, Yagyu H, Tabata O, Kim DN.

Nucleic Acids Res. 2019 Jan 10;47(1):93-102. doi: 10.1093/nar/gky1189.

7.

Comparison of glucose monitoring between Freestyle Libre Pro and iPro2 in patients with diabetes mellitus.

Kumagai R, Muramatsu A, Fujii M, Katakura Y, Ito K, Fujie K, Nakata Y, Hashimoto K, Yagyu H.

J Diabetes Investig. 2019 May;10(3):851-856. doi: 10.1111/jdi.12970. Epub 2018 Nov 29.

8.

Myeloid HMG-CoA (3-Hydroxy-3-Methylglutaryl-Coenzyme A) Reductase Determines Atherosclerosis by Modulating Migration of Macrophages.

Sakai K, Nagashima S, Wakabayashi T, Tumenbayar B, Hayakawa H, Hayakawa M, Karasawa T, Ohashi K, Yamazaki H, Takei A, Takei S, Yamamuro D, Takahashi M, Yagyu H, Osuga JI, Takahashi M, Tominaga SI, Ishibashi S.

Arterioscler Thromb Vasc Biol. 2018 Nov;38(11):2590-2600. doi: 10.1161/ATVBAHA.118.311664.

PMID:
30354246
9.

Loss of ACAT1 Attenuates Atherosclerosis Aggravated by Loss of NCEH1 in Bone Marrow-Derived Cells.

Yamazaki H, Takahashi M, Wakabayashi T, Sakai K, Yamamuro D, Takei A, Takei S, Nagashima S, Yagyu H, Sekiya M, Ebihara K, Ishibashi S.

J Atheroscler Thromb. 2019 Mar 1;26(3):246-259. doi: 10.5551/jat.44040. Epub 2018 Oct 4.

10.

Clearly Transparent Nanopaper from Highly Concentrated Cellulose Nanofiber Dispersion Using Dilution and Sonication.

Kasuga T, Isobe N, Yagyu H, Koga H, Nogi M.

Nanomaterials (Basel). 2018 Feb 12;8(2). pii: E104. doi: 10.3390/nano8020104.

11.

A candidate functional SNP rs7074440 in TCF7L2 alters gene expression through C-FOS in hepatocytes.

Piao X, Yahagi N, Takeuchi Y, Aita Y, Murayama Y, Sawada Y, Shikama A, Masuda Y, Nishi-Tatsumi M, Kubota M, Izumida Y, Sekiya M, Matsuzaka T, Nakagawa Y, Sugano Y, Iwasaki H, Kobayashi K, Yatoh S, Suzuki H, Yagyu H, Kawakami Y, Shimano H.

FEBS Lett. 2018 Feb;592(3):422-433. doi: 10.1002/1873-3468.12975. Epub 2018 Jan 23.

12.

Acute-onset type 1 diabetes mellitus caused by nivolumab in a patient with advanced pulmonary adenocarcinoma.

Kumagai R, Muramatsu A, Nakajima R, Fujii M, Kaino K, Katakura Y, Okumura N, Ohara G, Kagohashi K, Satoh H, Yagyu H.

J Diabetes Investig. 2017 Nov;8(6):798-799. doi: 10.1111/jdi.12627.

13.

Effect of sodium-glucose cotransporter 2 (SGLT2) inhibition on weight loss is partly mediated by liver-brain-adipose neurocircuitry.

Sawada Y, Izumida Y, Takeuchi Y, Aita Y, Wada N, Li E, Murayama Y, Piao X, Shikama A, Masuda Y, Nishi-Tatsumi M, Kubota M, Sekiya M, Matsuzaka T, Nakagawa Y, Sugano Y, Iwasaki H, Kobayashi K, Yatoh S, Suzuki H, Yagyu H, Kawakami Y, Kadowaki T, Shimano H, Yahagi N.

Biochem Biophys Res Commun. 2017 Nov 4;493(1):40-45. doi: 10.1016/j.bbrc.2017.09.081. Epub 2017 Sep 18.

PMID:
28928093
14.

Coarse-Grained Molecular Dynamics Model of Double-Stranded DNA for DNA Nanostructure Design.

Yagyu H, Lee JY, Kim DN, Tabata O.

J Phys Chem B. 2017 May 18;121(19):5033-5039. doi: 10.1021/acs.jpcb.7b03931. Epub 2017 May 10.

PMID:
28448145
15.

Reversible splenial lesion syndrome with a hyperosmolar hyperglycemic state and neuroleptic malignant syndrome caused by olanzapine.

Kaino K, Kumagai R, Furukawa S, Isono M, Muramatsu A, Fujii M, Muta Y, Asada T, Fujihara K, Yagyu H.

J Diabetes Investig. 2017 May;8(3):392-394. doi: 10.1111/jdi.12597. Epub 2017 Jan 6.

16.
17.

The C-terminal region of Reelin is necessary for proper positioning of a subset of Purkinje cells in the postnatal cerebellum.

Nakamura K, Beppu M, Sakai K, Yagyu H, Matsumaru S, Kohno T, Hattori M.

Neuroscience. 2016 Nov 12;336:20-29. doi: 10.1016/j.neuroscience.2016.08.039. Epub 2016 Aug 29.

PMID:
27586054
18.

Efficacy and Safety of Alirocumab in Japanese Patients With Heterozygous Familial Hypercholesterolemia or at High Cardiovascular Risk With Hypercholesterolemia Not Adequately Controlled With Statins - ODYSSEY JAPAN Randomized Controlled Trial.

Teramoto T, Kobayashi M, Tasaki H, Yagyu H, Higashikata T, Takagi Y, Uno K, Baccara-Dinet MT, Nohara A.

Circ J. 2016 Aug 25;80(9):1980-7. doi: 10.1253/circj.CJ-16-0387. Epub 2016 Jul 22. Erratum in: Circ J. 2016;80(11):2414.

19.

Fulminant Type 1 Diabetes Mellitus Presenting 11 Days after Delivery in a Patient of Mixed Genetic Background.

Furukawa S, Fujihara K, Kumagai R, Isono M, Yagyu H.

Intern Med. 2016;55(14):1881-5. doi: 10.2169/internalmedicine.55.6052. Epub 2016 Jul 15.

20.

Pioglitazone-induced Pulmonary Injury in a Very Elderly Patient.

Katayama K, Kumagai R, Isono M, Fujihara K, Yagyu H, Ohara G, Kagohashi K, Satoh H.

Intern Med. 2016;55(13):1779-82. doi: 10.2169/internalmedicine.55.6330. Epub 2016 Jul 1.

21.

Comparison of clinical characteristics in patients with type 2 diabetes among whom different antihyperglycemic agents were prescribed as monotherapy or combination therapy by diabetes specialists.

Fujihara K, Hanyu O, Heianza Y, Suzuki A, Yamada T, Yokoyama H, Tanaka S, Yagyu H, Shimano H, Kashiwagi A, Yamazaki K, Kawai K, Sone H.

J Diabetes Investig. 2016 Mar;7(2):260-9. doi: 10.1111/jdi.12387. Epub 2015 Jul 26.

22.

Transparent Conductive Nanofiber Paper for Foldable Solar Cells.

Nogi M, Karakawa M, Komoda N, Yagyu H, Nge TT.

Sci Rep. 2015 Nov 26;5:17254. doi: 10.1038/srep17254.

23.

Chemical Modification of Cellulose Nanofibers for the Production of Highly Thermal Resistant and Optically Transparent Nanopaper for Paper Devices.

Yagyu H, Saito T, Isogai A, Koga H, Nogi M.

ACS Appl Mater Interfaces. 2015 Oct 7;7(39):22012-7. doi: 10.1021/acsami.5b06915. Epub 2015 Sep 24.

PMID:
26402324
24.

New pyripyropene A derivatives, highly SOAT2-selective inhibitors, improve hypercholesterolemia and atherosclerosis in atherogenic mouse models.

Ohshiro T, Ohtawa M, Nagamitsu T, Matsuda D, Yagyu H, Davis MA, Rudel LL, Ishibashi S, Tomoda H.

J Pharmacol Exp Ther. 2015 Nov;355(2):299-307. doi: 10.1124/jpet.115.227348. Epub 2015 Sep 3.

25.

Identification of human ELOVL5 enhancer regions controlled by SREBP.

Shikama A, Shinozaki H, Takeuchi Y, Matsuzaka T, Aita Y, Murayama T, Sawada Y, Piao X, Toya N, Oya Y, Takarada A, Masuda Y, Nishi M, Kubota M, Izumida Y, Nakagawa Y, Iwasaki H, Kobayashi K, Yatoh S, Suzuki H, Yagyu H, Kawakami Y, Yamada N, Shimano H, Yahagi N.

Biochem Biophys Res Commun. 2015 Oct 2;465(4):857-63. doi: 10.1016/j.bbrc.2015.08.101. Epub 2015 Aug 28.

PMID:
26321664
26.

Circulating malondialdehyde-modified LDL-related variables and coronary artery stenosis in asymptomatic patients with type 2 diabetes.

Fujihara K, Suzuki H, Sato A, Kodama S, Heianza Y, Saito K, Iwasaki H, Kobayashi K, Yatoh S, Takahashi A, Yahagi N, Yagyu H, Sone H, Shimano H.

J Diabetes Res. 2015;2015:507245. doi: 10.1155/2015/507245. Epub 2015 Mar 26.

27.

Plasma cholesterol-lowering and transient liver dysfunction in mice lacking squalene synthase in the liver.

Nagashima S, Yagyu H, Tozawa R, Tazoe F, Takahashi M, Kitamine T, Yamamuro D, Sakai K, Sekiya M, Okazaki H, Osuga J, Honda A, Ishibashi S.

J Lipid Res. 2015 May;56(5):998-1005. doi: 10.1194/jlr.M057406. Epub 2015 Mar 9.

28.

Eicosapentaenoic acid/arachidonic acid ratio and smoking status in elderly patients with type 2 diabetes mellitus.

Okada K, Kotani K, Yagyu H, Ishibashi S.

Diabetol Metab Syndr. 2014 Aug 13;6(1):85. doi: 10.1186/1758-5996-6-85. eCollection 2014.

29.

Absence of Nceh1 augments 25-hydroxycholesterol-induced ER stress and apoptosis in macrophages.

Sekiya M, Yamamuro D, Ohshiro T, Honda A, Takahashi M, Kumagai M, Sakai K, Nagashima S, Tomoda H, Igarashi M, Okazaki H, Yagyu H, Osuga J, Ishibashi S.

J Lipid Res. 2014 Oct;55(10):2082-92. doi: 10.1194/jlr.M050864. Epub 2014 Jun 2.

30.

Effects of treatment with liraglutide on oxidative stress and cardiac natriuretic peptide levels in patients with type 2 diabetes mellitus.

Okada K, Kotani K, Yagyu H, Ando A, Osuga J, Ishibashi S.

Endocrine. 2014 Dec;47(3):962-4. doi: 10.1007/s12020-014-0246-6. Epub 2014 Apr 3. No abstract available.

31.

Body weight change and type 2 diabetes.

Kodama S, Horikawa C, Yoshizawa S, Fujihara K, Yachi Y, Tanaka S, Suzuki A, Hanyu O, Yagyu H, Sone H.

Epidemiology. 2013 Sep;24(5):778-9. doi: 10.1097/EDE.0b013e31829f6c31. No abstract available.

PMID:
23903884
32.

Effects of miglitol versus sitagliptin on postprandial glucose and lipoprotein metabolism in patients with type 2 diabetes mellitus.

Okada K, Yagyu H, Kotani K, Yamazaki H, Ozaki K, Takahashi M, Nagashima S, Osuga J, Ishibashi S.

Endocr J. 2013;60(7):913-22. Epub 2013 Apr 10.

33.

Adipose-specific lipoprotein lipase deficiency more profoundly affects brown than white fat biology.

Garcia-Arcos I, Hiyama Y, Drosatos K, Bharadwaj KG, Hu Y, Son NH, O'Byrne SM, Chang CL, Deckelbaum RJ, Takahashi M, Westerterp M, Obunike JC, Jiang H, Yagyu H, Blaner WS, Goldberg IJ.

J Biol Chem. 2013 May 17;288(20):14046-58. doi: 10.1074/jbc.M113.469270. Epub 2013 Mar 31.

34.

Macrophage lipoprotein lipase modulates the development of atherosclerosis but not adiposity.

Takahashi M, Yagyu H, Tazoe F, Nagashima S, Ohshiro T, Okada K, Osuga J, Goldberg IJ, Ishibashi S.

J Lipid Res. 2013 Apr;54(4):1124-34. doi: 10.1194/jlr.M035568. Epub 2013 Feb 3.

35.

Current smoking status may be associated with overt albuminuria in female patients with type 1 diabetes mellitus: a cross-sectional study.

Okada K, Osuga J, Kotani K, Yagyu H, Miyamoto M, Nagasaka S, Ishibashi S.

Tob Induc Dis. 2012 Aug 10;10(1):12. doi: 10.1186/1617-9625-10-12.

36.

Ezetimibe, an inhibitor of Niemann-Pick C1-like 1 protein, decreases cholesteryl ester transfer protein in type 2 diabetes mellitus.

Yagyu H, Nagashima S, Takahashi M, Miyamoto M, Okada K, Osuga J, Ishibashi S.

Endocr J. 2012;59(12):1077-84. Epub 2012 Jul 26.

37.

Liver-specific deletion of 3-hydroxy-3-methylglutaryl coenzyme A reductase causes hepatic steatosis and death.

Nagashima S, Yagyu H, Ohashi K, Tazoe F, Takahashi M, Ohshiro T, Bayasgalan T, Okada K, Sekiya M, Osuga J, Ishibashi S.

Arterioscler Thromb Vasc Biol. 2012 Aug;32(8):1824-31. doi: 10.1161/ATVBAHA.111.240754. Epub 2012 Jun 14.

PMID:
22701022
38.

Pegylated interferon-α2b and ribavirin combination therapy induces Hashitoxicosis followed by type 1 diabetes mellitus.

Yagyu H, Okada K, Sato S, Yamashita Y, Okada N, Osuga J, Nagasaka S, Sugano K, Ishibashi S.

Diabetes Res Clin Pract. 2012 Mar;95(3):e52-4. doi: 10.1016/j.diabres.2011.11.016. Epub 2011 Dec 10.

PMID:
22154462
39.

Urinary protein as a marker for systolic blood pressure reduction in patients with type 2 diabetes mellitus participating in an in-hospital diabetes education program.

Okada K, Miyamoto M, Kotani K, Yagyu H, Osuga J, Nagasaka S, Ishibashi S.

Hosp Pract (1995). 2011 Oct;39(4):70-5. doi: 10.3810/hp.2011.10.924.

PMID:
22056825
40.

Molecular analysis of a novel LCAT mutation (Gly179 → Arg) found in a patient with complete LCAT deficiency.

Wang XL, Osuga J, Tazoe F, Okada K, Nagashima S, Takahashi M, Ohshiro T, Bayasgalan T, Yagyu H, Okada K, Ishibashi S.

J Atheroscler Thromb. 2011;18(8):713-9. Epub 2011 May 20.

41.

Pyripyropene A, an acyl-coenzyme A:cholesterol acyltransferase 2-selective inhibitor, attenuates hypercholesterolemia and atherosclerosis in murine models of hyperlipidemia.

Ohshiro T, Matsuda D, Sakai K, Degirolamo C, Yagyu H, Rudel LL, Omura S, Ishibashi S, Tomoda H.

Arterioscler Thromb Vasc Biol. 2011 May;31(5):1108-15. doi: 10.1161/ATVBAHA.111.223552. Epub 2011 Mar 10.

PMID:
21393580
42.

Abrogation of neutral cholesterol ester hydrolytic activity causes adrenal enlargement.

Ohta K, Sekiya M, Uozaki H, Igarashi M, Takase S, Kumagai M, Takanashi M, Takeuchi Y, Izumida Y, Kubota M, Nishi M, Okazaki H, Iizuka Y, Yahagi N, Yagyu H, Fukayama M, Kadowaki T, Ohashi K, Ishibashi S, Osuga J.

Biochem Biophys Res Commun. 2011 Jan 7;404(1):254-60. doi: 10.1016/j.bbrc.2010.11.103. Epub 2010 Nov 25.

PMID:
21111707
43.

Depot-specific expression of lipolytic genes in human adipose tissues--association among CES1 expression, triglyceride lipase activity and adiposity.

Nagashima S, Yagyu H, Takahashi N, Kurashina T, Takahashi M, Tsuchita T, Tazoe F, Wang XL, Bayasgalan T, Sato N, Okada K, Nagasaka S, Gotoh T, Kojima M, Hyodo M, Horie H, Hosoya Y, Okada M, Yasuda Y, Fujiwara H, Ohwada M, Iwamoto S, Suzuki M, Nagai H, Ishibashi S.

J Atheroscler Thromb. 2011;18(3):190-9. Epub 2010 Nov 11.

44.

The critical role of neutral cholesterol ester hydrolase 1 in cholesterol removal from human macrophages.

Igarashi M, Osuga J, Uozaki H, Sekiya M, Nagashima S, Takahashi M, Takase S, Takanashi M, Li Y, Ohta K, Kumagai M, Nishi M, Hosokawa M, Fledelius C, Jacobsen P, Yagyu H, Fukayama M, Nagai R, Kadowaki T, Ohashi K, Ishibashi S.

Circ Res. 2010 Nov 26;107(11):1387-95. doi: 10.1161/CIRCRESAHA.110.226613. Epub 2010 Oct 14.

PMID:
20947831
45.

Lipid-lowering effects of ezetimibe for hypercholesterolemic patients with and without type 2 diabetes mellitus.

Okada K, Yagyu H, Kotani K, Miyamoto M, Osuga J, Nagasaka S, Ishibashi S.

Endocr J. 2010;57(10):903-8. Epub 2010 Aug 20.

46.

The correlation between CVR-R and carotid atherosclerosis in type 2 diabetes mellitus patients with diabetic neuropathy.

Miyamoto M, Kotani K, Yagyu H, Koibuchi H, Fujii Y, Konno K, Yamada T, Ishibashi S, Taniguchi N.

J Physiol Anthropol. 2010;29(4):149-52.

47.

Distinct association of serum FGF21 or adiponectin levels with clinical parameters in patients with type 2 diabetes.

Eto K, Tumenbayar B, Nagashima S, Tazoe F, Miyamoto M, Takahashi M, Ando A, Okada K, Yagyu H, Ishibashi S.

Diabetes Res Clin Pract. 2010 Jul;89(1):52-7. doi: 10.1016/j.diabres.2010.03.019. Epub 2010 May 7.

PMID:
20452080
48.

DGAT1 expression increases heart triglyceride content but ameliorates lipotoxicity.

Liu L, Shi X, Bharadwaj KG, Ikeda S, Yamashita H, Yagyu H, Schaffer JE, Yu YH, Goldberg IJ.

J Biol Chem. 2009 Dec 25;284(52):36312-23. doi: 10.1074/jbc.M109.049817. Epub 2009 Sep 24.

49.

Ablation of neutral cholesterol ester hydrolase 1 accelerates atherosclerosis.

Sekiya M, Osuga J, Nagashima S, Ohshiro T, Igarashi M, Okazaki H, Takahashi M, Tazoe F, Wada T, Ohta K, Takanashi M, Kumagai M, Nishi M, Takase S, Yahagi N, Yagyu H, Ohashi K, Nagai R, Kadowaki T, Furukawa Y, Ishibashi S.

Cell Metab. 2009 Sep;10(3):219-28. doi: 10.1016/j.cmet.2009.08.004.

50.

Hormone-sensitive lipase deficiency suppresses insulin secretion from pancreatic islets of Lep ob/ob mice.

Sekiya M, Yahagi N, Tamura Y, Okazaki H, Igarashi M, Ohta K, Takanashi M, Kumagai M, Takase S, Nishi M, Takeuchi Y, Izumida Y, Kubota M, Ohashi K, Iizuka Y, Yagyu H, Gotoda T, Nagai R, Shimano H, Yamada N, Kadowaki T, Ishibashi S, Osuga J.

Biochem Biophys Res Commun. 2009 Sep 25;387(3):511-5. doi: 10.1016/j.bbrc.2009.07.078. Epub 2009 Jul 18.

PMID:
19619509

Supplemental Content

Support Center